3009

Fujian Wanchen Biotechnology Group Co.,Ltd.XSEC:300972 Stock Report

Market Cap CN¥36.7b
Share Price
CN¥195.54
My Fair Value
CN¥203.38
3.9% undervalued intrinsic discount
1Y253.8%
7D5.2%
Portfolio Value
View

Fujian Wanchen Biotechnology Group Co.,Ltd.

XSEC:300972 Stock Report

Market Cap: CN¥36.7b

Fujian Wanchen Biotechnology GroupLtd (300972) Stock Overview

Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. More details

300972 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance4/6
Financial Health6/6
Dividends2/6

300972 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Fujian Wanchen Biotechnology Group Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Fujian Wanchen Biotechnology GroupLtd
Historical stock prices
Current Share PriceCN¥195.54
52 Week HighCN¥214.93
52 Week LowCN¥50.31
Beta-0.051
1 Month Change13.90%
3 Month Change27.32%
1 Year Change253.79%
3 Year Changen/a
5 Year Changen/a
Change since IPO443.62%

Recent News & Updates

Recent updates

Shareholder Returns

300972CN FoodCN Market
7D5.2%-2.0%-3.5%
1Y253.8%11.2%22.0%

Return vs Industry: 300972 exceeded the CN Food industry which returned 15.2% over the past year.

Return vs Market: 300972 exceeded the CN Market which returned 29.8% over the past year.

Price Volatility

Is 300972's price volatile compared to industry and market?
300972 volatility
300972 Average Weekly Movement8.9%
Food Industry Average Movement3.7%
Market Average Movement5.4%
10% most volatile stocks in CN Market9.3%
10% least volatile stocks in CN Market3.0%

Stable Share Price: 300972's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300972's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20117,904Li Qing Wangwww.vanchen.com

Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. It offers flammulina velutipes; and crab-flavored, white jade, seafood mushrooms, etc. The company was founded in 2011 and is based in Zhangpu, China.

Fujian Wanchen Biotechnology Group Co.,Ltd. Fundamentals Summary

How do Fujian Wanchen Biotechnology GroupLtd's earnings and revenue compare to its market cap?
300972 fundamental statistics
Market capCN¥36.69b
Earnings (TTM)CN¥764.15m
Revenue (TTM)CN¥44.00b
48.0x
P/E Ratio
0.8x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300972 income statement (TTM)
RevenueCN¥44.00b
Cost of RevenueCN¥39.11b
Gross ProfitCN¥4.88b
Other ExpensesCN¥4.12b
EarningsCN¥764.15m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Oct 22, 2025

Earnings per share (EPS)4.07
Gross Margin11.10%
Net Profit Margin1.74%
Debt/Equity Ratio56.1%

How did 300972 perform over the long term?

See historical performance and comparison

Dividends

0.4%
Current Dividend Yield
14%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/17 06:52
End of Day Share Price 2025/10/17 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fujian Wanchen Biotechnology Group Co.,Ltd. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wendan WangChina International Capital Corporation Limited
Katharine SongHSBC
Chenghui XiongHuatai Research